<DOC>
	<DOCNO>NCT01757808</DOCNO>
	<brief_summary>The purpose study assess safety ranolazine people pulmonary arterial hypertension ( PAH ) receive 1 background PAH therapy : ambrisentan , sildenafil , tadalafil , epoprostenol , treprostinil ( IV , SC , inhale ) , iloprost . The primary objective : - To estimate effect ranolazine administration acute hemodynamics . - To assess safety ranolazine acutely 6 hrs catheterization lab 12 week therapy - To assess change right ventricular function 12 week therapy .</brief_summary>
	<brief_title>A Study Ranolazine Acute Administration Short Term Administration Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>Pulmonary arterial hypertension medical disorder pressure blood vessel go right side heart lungs high normal . The increased blood pressure lung place strain heart . This strain cause heart pump less blood lung , cause physical symptom shortness breath tiredness . The added strain heart cause physical symptom swell foot abdomen . These symptom get bad time due decrease pump ability heart . This study use drug call ranolazine . This drug approve Food Drug Administration ( FDA ) treat chronic angina ( chest pain ) . However , since approve use PAH use study consider experimental .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>All subject age 1872 yr diagnosis PAH . PAH define idiopathic PAH , heritable PAH PAH associate collagen vascular disease , congenital heart disease ( repair ) , anorexigen use . A history PAH define hemodynamics diagnosis right heart catheterization define : mean PAP &gt; 25 mmHg normal PCWP &lt; 15 mm Hg rest PVR &gt; 3 Wood unit . Baseline 6MW &gt; 150 meter Patients receive FDA approve PAH monotherapy dual therapy medication : include , ambrisentan ( 5,10mg ) , sildenafil ( 60240mg ) , tadalafil ( 40mg ) , epoprostenol , treprostinil , iloprost stable dos &gt; 90days . Receiving conventional therapy clinically indicate ( oxygen , calcium channel blocker , digoxin ) dose unchanged precede 30 day prior enrollment . This exclude anticoagulant ( warfarin ) patient 's dose may stable patient cardiac catheterization baseline within 30 day enrollment warfarin held . PAH Category IIIV Category I associate etiology : HIV , portopulmonary disease All subject monotherapy calcium blocker `` calcium blocker responder '' irrespective therapy All subject receive CY3P4 inducer ( i.e . bosentan ) Subjects pulmonary hypertension due significant interstitial lung disease , chronic obstructive pulmonary disease , congestive heart failure , valvular heart disease Subjects ( World Health Organization ( WHO ) functional Class I Class IV Subjects total lung capacity ( TLC ) &lt; 60 % predicted Subjects significant obstructive lung disease FEV1/FVC ratio &lt; 70 % predicted Subjects hypotension define systolic arterial pressure &lt; 90 mmHg baseline Subjects hypertension define systolic arterial pressure &gt; 140 mmHg baseline diastolic arterial pressure &gt; 90 mmHg despite adequate medical therapy . Subjects impaired renal function define estimate glomerular filtration rate ( eGFR ) less 45 mL/min/BSA ( BSA=1.73m2 ) calculate Modification Diet Renal Disease ( MDRD ) equation : Patients eGFR 4550 mL/min/BSA may enrol discussion data safety monitor board . Patients eGFR â‰¥ 50 mL/min/BSA may enrol without discussion . Subjects liver function test ( transaminase ( AST/ALT ) , total bilirubin , alkaline phosphatase ) &gt; 2X normal value Subjects acutely decompensated heart failure require hospitalization medication adjustment hospitalization cause within previous 30 day prior screen Subjects may receive investigational agent Subjects leave ventricular ejection fraction &lt; 45 % leave ventricular shorten fraction &lt; 0.2 Subjects acute myocardial infarction within 90 day prior screen Subjects take nitrate medical problem Subjects recent ( &lt; 180 day ) history pulmonary embolism verify ventilation/perfusion scan , angiogram spiral CT scan Pregnant lactate woman Subjects history current drug abuse include alcohol History gastric bypass surgery History sinus atrioventricular nodal disease ie . sick sinus syndrome , second third degree heart block .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PAH</keyword>
	<keyword>Ranolazine</keyword>
	<keyword>right ventricle</keyword>
	<keyword>Safety</keyword>
	<keyword>cardiopulmonary exercise testing</keyword>
</DOC>